XML 53 R42.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Collaboration Agreements, License Agreement and Revenues - AstraZeneca U.S./RoW Agreement - Additional Information (Detail) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Accounts receivable from related parties $ 37,083   $ 12,553
Related cost of goods sold 25,753 $ 3,491  
AstraZeneca U.S./RoW Agreement [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Cumulative catch-up net adjustment 25,700    
Related accounts receivable 26,000    
Related accrued liabilities 11,500   $ 11,200
Related cost of goods sold $ 21,100